title: Is an ounce of prevention worth a pound of cure?
authors.affiliation: Department of Pediatrics, The Ohio State University, Children's Hospital, 700 Children's Drive, Columbus, Ohio 43205, USA. tgross@chi.osu.edu
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Gross
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000517:prevention & control* / Q000821:virology; D016133:Polymerase Chain Reaction / Q000379:methods; D011292:Premedication; D000069283:Rituximab; D014775:Virus Activation
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab